New Speciality Standards New Speciality Standards Management of End Stage Ankle Arthritis 05 April 2025 Click here to access the latest BOFAS-BOA Standards for management of End Stage Ankle Arthritis Read more
Memorandum of Understanding with Royal College of Podiatry Memorandum of Understanding with Royal College of Podiatry 12 November 2024 The MOU between the RCP and BOFAS is a landmark document outlining similarities and differences between the two professional groups. This is pertinent to all surgeons and patients. Click for more details. Read more
Australian Orthopaedic F&A Society Australian Orthopaedic F&A Society Seeking Expressions of Interest for August 2026 11 November 2024 The Australian Orthopaedic Foot & Ankle Society is seeking expressions of interest from BOFAS Members interested in joining their 2026 annual meeting in Singapore. Read more
20Apr2026 BOFAS Diabetic Foot Principles Course 20/04/2026 Read more BOFAS Diabetic Foot Principles Course 20th April 2026, Delta by Marriott Hotel, Milton Keynes £150.00 Read more
29Apr2026 BOFAS Trauma Course 29/04/2026 Read more BOFAS Trauma Course 29th April 2026, Bristol £150 Read more
15May2026 BOFAS Allied Health Professionals Course 15/05/2026 Read more BOFAS Allied Health Professionals Course 15th May 2026, Bournemouth Read more
2Jul2026 BOFAS Basics & Advanced Arthroscopy Skills Course 02/07/2026 Read more BOFAS Basics & Advanced Arthroscopy Skills Course 2nd-3rd July 2026, Solihull Read more
1Oct2026 BOFAS Principles Course 01/10/2026 Read more BOFAS Principles Course 1st-2nd October 2026, Glasgow £325.00 Read more
6May2026 Nordic Foot & Ankle Congress 06/05/2026 - 07/05/2026 Read more Nordic Foot & Ankle Congress BOFAS Members have been invited to the Nordic Foot & Ankle Congress May 6/7 2026 in Oslo. Read more
Togay Koç / 11 July 2022 / Categories: Abstracts, 2016, Podium Foot and ankle injections - are they worth it? D. Marsland, J. Grice, J. Calder Introduction: Injections are used to treat a wide variety of pathologies. Our aim was to evaluate the efficacy and safety of foot and ankle injections in our clinic. Materials and methods: We performed a retrospective review of notes and a telephone questionnaire audit into the clinical outcome of all patients who underwent an injection of the foot or ankle in a year. All procedures were performed in an out-patient setting by a consultant musculoskeletal radiologist using either ultrasound or X-ray guidance, with a minimum of two year follow-up. According to the pathology treated, the type of injection included depomedrone, hyaluronic acid and high volume saline injections. Results: Overall 410/446 (92%) patients reported a significant improvement in symptoms and 227 (62%) reported complete resolution of their pain, with 127 (28%) remaining asymptomatic at two year follow-up. The mode time of recurrence of pain was three months. 59 (13%) underwent a further injection and 102 (23%) underwent operative intervention within the follow-up period. There were no reported infections. Complications occurred in two percent of patients, including steroid flare, pain and plantar plate ruptures. Conclusion: Injections are a safe and effective option for treating a variety of foot and ankle conditions and reduce the need for surgery. They are particularly effective for the treatment of ankle soft tissue impingement. They appear ineffective in providing significant improvement in pain for longer than three months in conditions such as plantar fasciitis and hallux rigidus. Print 1168 Tags: AnkleHallux RigidusPlantar Fasciitis